Sevoflurane and Hyperperfusion Syndrome

• Status: Unknown status
• Trial end date: 2018-09-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the present study is to evaluate the effect of sevoflurane postconditioning on the incidence of postoperative hyperperfusion syndrome following revascularization surgery in moyamoya patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Sevoflurane

Criteria

Inclusion Criteria:

• Adult patients receiving cerebral revascularization surgery due to moyamoya disease

Exclusion Criteria:

• Patients who do not agree to the study

• Patients with uncontrolled diabetes or hypertension

• Patients using cyclooxygenase2 inhibitor or with previously using cyclooxygenase2 inhibitor

• Patients with acute renal failure

• Patients with previous intervention related with moyamoya disease